Chemotherapy is a common treatment for TNBC, but studies show that only 40 percent of tumors respond to the treatment — meaning the tumor reduced in size partially or completely. Chemotherapy has ...
A research team at Johns Hopkins Medicine has created and trained a machine learning model to calculate percent necrosis (PN)—or, what percentage of a tumor is "dead" and no longer active—in patients ...
Machine Learning Applied to Electronic Health Records: Identification of Chemotherapy Patients at High Risk for Preventable Emergency Department Visits and Hospital Admissions Our final proposed model ...
The reliable predictive markers to identify which patients with advanced non-small cell lung cancer tumors (NSCLC) will achieve durable clinical benefit (DCB) for chemo-immunotherapy are needed. In ...
The powerful chemotherapy drug cisplatin has been used since the late 1970s to treat a variety of cancers. It's highly effective against solid tumors and is often a core element of treatment for ...
In mouse tests, magnet-guided algae microbots helped chemotherapy penetrate bladder tumours more deeply, cutting tumour ...
Platinum-based therapy is an integral part of the standard treatment for ovarian cancer. However, despite extensive research spanning several decades, the identification of dependable predictive ...
A study led by Dr. Steven Chen at Sylvester Comprehensive Cancer Center and published July 25 in Cell Reports identifies and validates a 10-gene biomarker that potentially predicts whether a stage II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results